BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2014
View Archived Issues
Clinical phase I/II results of gene therapy for Becker muscular dystrophy
Read More
Phase II clinical results for a three-drug combination against HCV infection
Read More
GlaxoSmithKline plans phase II study of GSK-2269557 for acute exacerbation of COPD
Read More
New antagonists of S1P3 revert neurodegeneration and neuroinflammation
Read More
Nippon Kayaku launches infliximab biosimilar in Japan
Read More
Osteopontin RNA aptamer shows potential for the treatment of heart failure
Read More
LCZ-696 granted accelerated assessment by CHMP in Europe
Read More
Fullerene polyaminocaproic acid tested against HSV infection
Read More
Medicines for Malaria Venture collaborates with Cipla and Strides
Read More
UCB and Daiichi Sankyo partner to commercialize lacosamide in Japan
Read More
Aerocrine plans rights issue to fund commercialization of asthma diagnostic
Read More
Bukwang Pharmaceutical acquires Contera Pharma
Read More
Fingolimod fails to achieve endpoint in phase III trial in PPMS
Read More
Rinat Neuroscience discloses new anti-glucagon receptor antibodies
Read More
Incyte patents novel JAK-1 inhibitors
Read More
Roche patent reports new anti-HBV compounds
Read More
New mu opioid receptor antagonists designed at Dr August Wolff
Read More
Suzhou Vivotide Biotechnologies discloses novel VEGFR-1 inhibitors
Read More
Dynavax regains rights to DV-1179 under GSK collaboration
Read More
Mochida seeks approval in Japan for Lexapro in social anxiety disorder
Read More
Janssen files for manufacturing and distribution approval for ibrutinib in Japan
Read More
MSD and Kyorin sign Japanese comarketing agreement for desloratadine
Read More
EMA accepts for review Imbruvica submission for Waldenstrom's macroglobulinemia
Read More